AHR and atopic eczema: The aryl hydrocarbon receptors (AHR) agonist (tapinarof): For the treatment of psoriasis and atopic dermatitis, tapinarof, a new, first-in-class, small-molecule topical therapy aryl hydrocarbon receptor (AhR)-modulating drug, is currently undergoing clinical testing.